<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">CYANOCOBALAMIN</span><br/>(sye-an-oh-koe-bal'a-min)<br/><span class="topboxtradename">Anacobin <img border="0" src="../images/maple.gif"/>, </span><span class="topboxtradename">Bedoz <img border="0" src="../images/maple.gif"/>, </span><span class="topboxtradename">Betalin 12, </span><span class="topboxtradename">Cobex, </span><span class="topboxtradename">Crystamine, </span><span class="topboxtradename">Crysti-12, </span><span class="topboxtradename">Cyanabin, </span><span class="topboxtradename">Cyanoject, </span><span class="topboxtradename">Kaybovite, </span><span class="topboxtradename">Nascobal, Nascobal Redisol, </span><span class="topboxtradename"> Rubesol, </span><span class="topboxtradename"> Rubion <img border="0" src="../images/maple.gif"/>, </span><span class="topboxtradename">Rubramin PC<br/></span><b>Classifications:</b> <span class="classification">hormone and synthetic substitute</span>; <span class="classification">vitamin b<sub>12</sub>
</span><br/><b>Pregnancy Category: </b>AC (parenteral)<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>25 mcg, 50 mcg, 100 mcg, 250 mcg tablets; 400 mcg/unit, 500 mcg/0.1 mL nasal gel; 500 mcg/0.1 mL nasal spray</p>
<h1><a name="action">Actions</a></h1>
<p>Vitamin B<sub>12</sub> is a cobalt-containing B complex vitamin produced by <i>Streptomyces griseus</i>. Essential for normal growth, cell reproduction, maturation of RBCs, nucleoprotein synthesis, maintenance of nervous system
         (myelin synthesis), and believed to be involved in protein and carbohydrate metabolism. Also acts as coenzyme in various biologic
         reactions. Vitamin B<sub>12</sub> deficiency results in megaloblastic anemia, dysfunction of spinal cord with paralysis, GI lesions.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Therapeutically effective for treatment of vitamin B<sub>12</sub> deficiency and pernicious anemia.
      </p>
<h1><a name="uses">Uses</a></h1>
<p>Vitamin B<sub>12</sub> deficiency due to malabsorption syndrome as in pernicious (Addison's) anemia, sprue; GI pathology, dysfunction, or surgery;
         fish tapeworm infestation, and gluten enteropathy. Also used in B<sub>12</sub> deficiency caused by increased physiologic requirements or inadequate dietary intake, and in vitamin B<sub>12</sub> absorption (Schilling) test.
      </p>
<h1><a name="unlabeleduses">Unlabeled Uses</a></h1>
<p>To prevent and treat toxicity associated with sodium nitroprusside.</p>
<h1><a name="contrain">Contraindications</a></h1>
<p>History of sensitivity to vitamin B<sub>12</sub>, other cobalamins, or cobalt; early Leber's disease (hereditary optic nerve atrophy), indiscriminate use in folic acid deficiency.
         Safe use during pregnancy [category A, category C (parenteral)], lactation.
      </p>
<h1><a name="precaution">Cautious Use</a></h1>
<p>Heart disease, anemia, pulmonary disease.</p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Vitamin B<sub>12</sub> Deficiency</span><br/><span class="rdage">Adult:</span> <span class="rdroute">IM/Deep SC</span> 30 mcg/d for 510 d, then 100200 mcg/mo<br/><span class="rdage">Child:</span> <span class="rdroute">IM/Deep SC</span> 100 mcg doses to a total of 15 mg over 2 wk, then 60 mcg/mo<br/><br/><span class="indicationtitle">Pernicious Anemia</span><br/><span class="rdage">Adult:</span> <span class="rdroute">IM/Deep SC</span> 1001000 mcg/d for 23 wk, then 1001000 mcg q24wk <span class="rdroute">Intranasal</span> one pump in one nostril once weekly<br/><span class="rdage">Child:</span> <span class="rdroute">IM</span> 3050 mcg/d times 2 wk to total of 1000 mcg, then 100 mcg/mo<br/><span class="rdage">Infant:</span> <span class="rdroute">IM</span> 1000 mcg/d times at least 2 wk, then 50 mcg/mo<br/><br/><span class="indicationtitle">Diagnosis of Megaloblastic Anemia</span><br/><span class="rdage">Adult:</span> <span class="rdroute">IM/Deep SC</span> 1 mcg/d for 10 d while maintaining a low folate and vitamin B<sub>12</sub> diet<br/><br/><span class="indicationtitle">Schilling Test</span><br/><span class="rdage">Adult:</span> <span class="rdroute">IM/Deep SC</span> 1000 mcg times 1 dose<br/><br/><span class="indicationtitle">Nutritional Supplement</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 125 mcg/d<br/><span class="rdage">Child:</span> <span class="rdroute">PO</span>
<i> 0.3 mcg/d; <i><img src="../images/special/greaterorequal.gif"/>1 y:</i> 1 mcg/d<br/></i></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Oral</span><br/><ul>
<li>PO preparations may be mixed with fruit juices. However, administer promptly since ascorbic acid affects the stability of
            vitamin B<sub>12</sub>.
         </li>
<li>Administration of oral vitamin B<sub>12</sub> with meals increases its absorption.
         </li>
</ul><span class="adminroutetype">Subcutaneous/</span><span class="adminroutetype">Intramuscular</span><br/><ul>
<li>Give deep SC by slightly tenting the skin at the injection site.</li>
<li>IM may be given into any normal IM injection site.</li>
<li>Preserved in light-resistant containers at room temperature preferably at 15°30° C (59°86°
            F) unless otherwise directed by manufacturer.
         </li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead"> Body as a Whole:</span> Feeling of swelling of body, <span class="speceff-life">anaphylactic shock, sudden death</span>. <span class="typehead">CV:</span> Peripheral vascular thrombosis, pulmonary edema, CHF. <span class="typehead">GI:</span> Mild transient diarrhea. <span class="typehead">Hematologic:</span> Unmasking of polycythemia vera (with correction of vitamin B<sub>12</sub> deficiency). <span class="typehead">Metabolic:</span> Hypokalemia. <span class="typehead"> Skin:</span>  Itching, rash, flushing. <span class="typehead"> Special Senses:</span> Severe optic nerve atrophy (patients with Leber's disease). 
      <h1><a name="dtintefer">Diagnostic Test Interference</a></h1>
<p>Most antibiotics, methotrexate, and pyrimethamine may produce invalid diagnostic <span class="alt">blood assays for vitamin B<sub>12</sub>.</span> Possibility of false-positive test for <span class="alt">intrinsic factor antibodies.</span>
</p>
<h1><a name="interactions">Interactions</a></h1><span class="typehead"> Drug:</span>
<b> Alcohol,</b>
<b>aminosalicylic acid,</b>
<b>neomycin,</b>
<b>colchicine</b> may decrease absorption of oral cyanocobalamin; <b>chloramphenicol</b> may interfere with therapeutic response to cyanocobalamin. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> Intestinal absorption requires presence of intrinsic factor in terminal ileum. <span class="typehead">Distribution:</span> Widely distributed; principally stored in liver, kidneys, and adrenals; crosses placenta, excreted in breast milk. <span class="typehead">Metabolism:</span> Converted in tissues to active co-enzymes; enterohepatically cycled. <span class="typehead">Elimination:</span> 5095% of doses <img src="../images/special/greaterorequal.gif"/>100 mcg are excreted in urine in 48 h. <span class="typehead">Half-Life:</span> 6 d (400 d in liver). 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Lab tests: Before initiation of therapy, reticulocyte and erythrocyte counts, Hgb, Hct, vitamin B<sub>12</sub>, and serum folate levels should be determined; then repeated between 5 and 7 d after start of therapy and at regular intervals
            during therapy. Monitor potassium levels during the first 48 h. Conversion to normal erythropoiesis increases erythrocyte
            potassium requirement and can result in severe hypokalemia and sudden death.
         </li>
<li>Obtain a careful history of sensitivities. Sensitization to cyanocobalamin can take as long as 8 y to develop.</li>
<li>Monitor vital signs in patients with cardiac disease and in those receiving parenteral cyanocobalamin, and be alert to symptoms
            of pulmonary edema, which generally occur early in therapy.
         </li>
<li>Therapeutic response to drug therapy is usually dramatic, occurring within 48 h. Effectiveness is measured by laboratory values
            and improvement in manifestations of vitamin B<sub>12</sub> deficiency.
         </li>
<li>Characteristically, reticulocyte concentration rises in 34 d, peaks in 58 d, and then gradually declines as erythrocyte
            count and Hgb rise to normal levels (in 46 wk).
         </li>
<li>Obtain a complete diet and drug history and inquire into alcohol drinking patterns for all patients receiving cyanocobalamin
            to identify and correct poor habits.
         </li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Notify physician of any intercurrent disease or infection. Increased dosage may be required.</li>
<li>To prevent irreversible neurologic damage resulting from pernicious anemia, drug therapy must be continued throughout life.</li>
<li>Rich food sources of B<sub>12</sub> are nutrient-added breakfast cereals, vitamin B<sub>12</sub>-fortified soy milk, organ meats, clams, oysters, egg yolk, crab, salmon, sardines, muscle meat, milk, and dairy products.
         </li>
<li>Do not breast feed while taking this drug.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>